Clinical Trials Browser

Phase 2 × Recurrence × quizartinib × Clear all

NCT01565668 2019-12-27

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 2 Completed

76 enrolled 17 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT00989261 2019-12-11

ACE

Phase 2 Completed

333 enrolled 23 charts

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute